Xing Ling

 

Spearheading the Global Expansion of China's Top Pharma & TCM Firms
把中国顶尖药品推向世界

Home

About Us Contact Us Links FAQ  DISTRIBUTORS WANTED  


Traditional Chinese Medicine
GuiLingJi
DingKunDan
YuPingFeng
BanLanGen
Cooling & Detox Liquid
WuJiBaiFengWan
ShengTianQiPian
YinQiaoJieDuPian
JingZhiGuanXinPian
HuGanNingPian
FuFangDanShenPian
XiaoYaoWan
HuoXiangZhengQiWan
GuiPiWan
QiJuDiHuangWan
ShiQuanDaBuWan
JinSuoGuJingWan
LiuWeiDiHuangWan
BuZhongYiQiWan
ShuJinHuoXuePian
HouTouJunPian

Scientific Chinese Medicine                  
Kardigen
Mobix
Dioscornin
Livotide

Supplements  
Cartrix-M

Treated Herbs
Herb Library

Western Drugs

Watch TV Ads
(in Chinese)
GuiLingJi
RuiZhu Eyedrops

Distributors Wanted


 

 


Mobix is Poised to Become No. 1 Product for Xing Ling
19 September 2007


Mobix, our Scientific Chinese Medicine (SCM) for treating arthritis, was successfully launched to Chinese Physicians in Singapore on 16 July 2007. Prior to its much anticipated debut, there was already strong interest as many physicians had independently heard about Mobix through the worldwide TCM grapevine, as Sailonggu (Mobix’s Chinese name) is widely regarded as the best replacement for Tiger Bones.

Tiger Bones have long been the Gold Standard in TCM for treating arthritis, and this has led to the near extinction of the big cat. In response, China banned the trade in all tiger parts in 1993, resulting in a rush to find a replacement for tiger bones. Mobix was developed after 10 years of intensive research, and has been trumpeted as the closest match to tiger bones in terms of amino acid profile and treatment efficacy. Mobix’s main ingredient is the bone of the hill mammal Myospalax baileyi, which is found in abundance on the Qinghai-Tibetan plateau. As an indication of Mobix’s success, Xing Ling’s sales representatives took a substantial lot of pre-launch orders.

Arthritis is a basket term for over 100 diseases involving joint inflammation including osteoarthritis, rheumatoid arthritis and gout. It is the leading cause of disability for those aged 55 and above. In the US alone, 15% (or 46 million) of Americans suffer from it. With the global trend towards an aging population, and the concomitant rise in arthritic cases, the long term sales outlook for Mobix looks rosy.

Within a few weeks of its launch, Mobix has received highly positive feedback from physicians, who were largely impressed by the sheer speed of its efficacy in relieving joint pain. This was especially so, in light of the fact that most TCM take a long time to work. Coupled with the fact that the mainstay of medical cases seen by Chinese Physicians in Singapore are joint related (eg. twisted ankle, sports injury, arthritic pain), Mobix is poised to become the number one product for Xing Ling within the next 6 months in terms of sales. Already, many physicians have repeated their purchases.

Mobix effectively controls the symptoms of the two main forms of arthritis, namely osteoarthritis and rheumatoid arthritis, providing pain relief and anti-inflammation within a short time frame. Unlike conventional supplements like glucosamine which takes an average of one month to show results, Mobix takes effect in as little as 5 days, with the full treatment course lasting just 20 to 30 days. In contrast, the treatment course for glucosamine spans at least 6 months. After treatment, users need only take a low maintenance dose for sustained pain relief. Mobix has a significant efficacy of as high as 90.33% with minimal side effects. It works quickly by improving blood circulation to the joints, promoting the formation of collagen tissue, nourishing the liver and kidneys, and boosting the immune system. Mobix also strengthens bones and muscles, which help to take pressure off the joints, further relieving joint pain.

 

 

 

 

 

 

 

© Copyright 2005-2006 Xing Ling International Pte Ltd. All Rights Reserved.
66 Tannery Lane #01-05A Sindo Building Singapore 347805    Tel: (65) 6100-1707    Fax: (65) 6741-1007  
 gloria_seow@xing-ling.com